Amit Nathwani is the founder of Freeline Therapeutics. Freeline Therapeutics has raised $160M in total funding. Latest round: Series B.
Amit Nathwani is Freeline Therapeutics' CSO, a company that builds on his pioneering work in AAV gene therapy. His research has been instrumental in developing treatments for chronic systemic diseases, notably Haemophilia B through his academic work at UCL.
Full founder directory · Investor directory · Company funding database · Fundraising library